Robert G. Shepler
Director · Akoya Biosciences, Inc.
Individual
- 2025
- Jul 8, 2025
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Robert G. Shepler's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- BAKER BROS. ADVISORS LP - $118.63M in KOD purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $117.62M in ARTV purchases and sales in the last 12 months
- SVF Pauling (Cayman) Ltd - $116.40M in RLAY purchases and sales in the last 12 months
- Bain Capital Life Sciences Investors, LLC - $115.00M in HTFL purchases and sales in the last 12 months
- Michael Simanovsky - $110.65M in SNDA purchases and sales in the last 12 months
- Mayukh Sukhatme - $109.13M in ROIV purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Robert G. Shepler?
Robert G. Shepler is a corporate insider, tracked as Director of Akoya Biosciences, Inc. (AKYA). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Robert G. Shepler last file a Form 4?
The only primary Form 4 on record is dated 8 July 2025.